Neuro-Oncology News

Americans consider cancer the most significant health care challenge in the United States, according to results of the Mayo Clinic National Health Checkup survey.

Vinblastine appeared well-tolerated in children with pediatric low-grade glioma, and it conferred OS and PFS outcomes similar to those of other treatments, according to data from a single-arm phase 2 study.

Postoperative stereotactic radiosurgery conferred equivalent OS as whole-brain radiation therapy but improved preservation of cognitive functioning and quality of life in patients with resected metastatic brain disease, according to phase 3 trial results presented at the ASTRO Annual Meeting.

Extraordinary therapeutic advances, a renewed bipartisan commitment to medical research and the launch of the national cancer moonshot initiative have reinforced the importance of scientific investigation in the fight against cancer.

Vice President Joe Biden outlined a plan to improve the efficiency and transparency of the U.S. clinical research system as part of the national cancer moonshot initiative.

The U.S. death rate of children and adolescents with cancer continues to decline with a 20% drop over a 15-year span, according to a data brief report from the CDC’s National Center for Health Statistics.

The National Comprehensive Cancer Network Oncology Research Program awarded grants to three investigators who are studying bavituximab as part of combination treatments for cancer.

The FDA approved the first generation of proton beam therapy nearly 30 years ago.

The national cancer moonshot initiative’s blue ribbon panel delivered 10 recommendations to form a 5-year research blueprint to accelerate progress against cancer at the NCI’s National Cancer Advisory Board meeting.

Whole-brain radiotherapy failed to extend OS and improve quality of life among patients with non–small cell lung cancer and brain metastases, according to the results of a randomized phase 3 noninferiority trial.